AB
The startup develops a non-invasive blood test that utilizes biomarker analysis for the early detection of lung cancer. This technology enables patients to identify lung cancer at a treatable stage, significantly improving survival rates.
Updated 4 months ago
Funding
$160K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a non-invasive blood test that utilizes biomarker analysis for the early detection of lung cancer. This technology enables patients to identify lung cancer at a treatable stage, significantly improving survival rates.